熔点	122-128 ºC
密度	1.19

没有数据	没有数据

来源	SDS样本
TCI	浏览或下载

产品合成路线

更多

名称	CAS号
Oxcarbazepine	28721-07-5	查看

更多

文章

同行评议文献

A new aspect of tolbutamide metabolism in the rabbit: the role of 1-butyl-3-(p-formylphenyl)sulphonylurea.K Washio et al.The Journal of pharmacy and pharmacology, 45(3), 231-233 (1993-03-01) Evaluation of the in vitro/in vivo drug interaction potential of BST204, a purified dry extract of ginseng, and its four bioactive ginsenosides through cytochrome P450 inhibition/induction and UDP-glucuronosyltransferase inhibition.Yu Fen Zheng et al.Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 68, 117-127 (2014-03-19) Effects of CYP2C19 and CYP2C9 genetic polymorphisms on the disposition of and blood glucose lowering response to tolbutamide in humans.Ji-Hong Shon et al.Pharmacogenetics, 12(2), 111-119 (2002-03-05) Inhibitory mechanisms of celastrol on human liver cytochrome P450 1A2, 2C19, 2D6, 2E1 and 3A4.Chunhuan Jin et al.Xenobiotica; the fate of foreign compounds in biological systems, 45(7), 571-577 (2015-03-27) Impact of CYP2C9 and CYP2C19 polymorphisms on tolbutamide kinetics and the insulin and glucose response in healthy volunteers.Julia Kirchheiner et al.Pharmacogenetics, 12(2), 101-109 (2002-03-05) Tolbutamide as a model drug for the study of enzyme induction and enzyme inhibition in the rat.D J Back et al.British journal of pharmacology, 81(3), 557-562 (1984-03-01) Validation of the tolbutamide metabolic ratio for population screening with use of sulfaphenazole to produce model phenotypic poor metabolizers.M E Veronese et al.Clinical pharmacology and therapeutics, 47(3), 403-411 (1990-03-01) Simultaneous determination of tolbutamide and its hydroxy and carboxy metabolites in plasma and urine by high-performance liquid chromatography.J Keal et al.Journal of chromatography, 378(1), 237-241 (1986-05-28) Inhibition of cytochrome P450 by ethambutol in human liver microsomes.Sang Yoon Lee et al.Toxicology letters, 229(1), 33-40 (2014-06-10) Tolbutamide hydroxylation in humans: lack of bimodality in 106 healthy subjects.M E Veronese et al.Pharmacogenetics, 3(2), 86-93 (1993-04-01) Effects of artemisinin antimalarials on Cytochrome P450 enzymes in vitro using recombinant enzymes and human liver microsomes: potential implications for combination therapies.Therese Ericsson et al.Xenobiotica; the fate of foreign compounds in biological systems, 44(7), 615-626 (2014-01-10) Simultaneous determinations of tolbutamide and its hydroxy and carboxy metabolites in serum and urine: application to pharmacokinetic studies of tolbutamide in the rat.S St-Hilaire et al.Journal of pharmaceutical sciences, 78(10), 863-866 (1989-10-01) Inhibitory mechanisms of celastrol on human liver cytochrome P450 1A2, 2C19, 2D6, 2E1 and 3A4.Chunhuan Jin et al.Xenobiotica; the fate of foreign compounds in biological systems, 45(7), 571-577 (2015-03-27) Effects of Guanxinning injection on rat cytochrome P450 isoforms activities in vivo and in vitro.Yue Yu et al.Xenobiotica; the fate of foreign compounds in biological systems, 45(6), 481-487 (2014-12-17) Inhibition of CYP2C9 by selective serotonin reuptake inhibitors: in vitro studies with tolbutamide and (S)-warfarin using human liver microsomes.A Hemeryck et al.European journal of clinical pharmacology, 54(12), 947-951 (1999-04-07) Impact of CYP2C9 and CYP2C19 polymorphisms on tolbutamide kinetics and the insulin and glucose response in healthy volunteers.Julia Kirchheiner et al.Pharmacogenetics, 12(2), 101-109 (2002-03-05) A new aspect of tolbutamide metabolism in the rabbit: the role of 1-butyl-3-(p-formylphenyl)sulphonylurea.K Washio et al.The Journal of pharmacy and pharmacology, 45(3), 231-233 (1993-03-01) Tolbutamide as a model drug for the study of enzyme induction and enzyme inhibition in the rat.D J Back et al.British journal of pharmacology, 81(3), 557-562 (1984-03-01) Influences of Re Du Ning Injection, a traditional Chinese medicine injection, on the CYP450 activities in rats using a cocktail method.Ting Geng et al.Journal of ethnopharmacology, 174, 426-436 (2015-09-01) Metabolic drug-drug interaction potential of macrolactin A and 7-O-succinyl macrolactin A assessed by evaluating cytochrome P450 inhibition and induction and UDP-glucuronosyltransferase inhibition in vitro.Soo Hyeon Bae et al.Antimicrobial agents and chemotherapy, 58(9), 5036-5046 (2014-06-04) In vitro and in vivo characterization of 13 CYP2C9 allelic variants found in Chinese Han population.Guo-Xin Hu et al.Drug metabolism and disposition: the biological fate of chemicals, 43(4), 561-569 (2015-01-24) An HPLC method for the simultaneous determination of tolbutamide and its metabolites in plasma.P Pecorari et al.Il Farmaco; edizione pratica, 36(1), 7-12 (1981-01-01) Excretion of tolbutamide metabolites in young and old subjects.A K Miller et al.European journal of clinical pharmacology, 38(5), 523-524 (1990-01-01) A species comparison of tolbutamide metabolism in precision-cut liver slices from rats and dogs. Qualitative and quantitative sex differences.P Dogterom et al.Drug metabolism and disposition: the biological fate of chemicals, 21(4), 705-709 (1993-07-01) Effect of albumin on phenytoin and tolbutamide metabolism in human liver microsomes: an impact more than protein binding.Cuyue Tang et al.Drug metabolism and disposition: the biological fate of chemicals, 30(6), 648-654 (2002-05-23) Impaired (S)-warfarin metabolism catalysed by the R144C allelic variant of CYP2C9.A E Rettie et al.Pharmacogenetics, 4(1), 39-42 (1994-02-01) Use of tolbutamide as a substrate probe for human hepatic cytochrome P450 2C9.J O Miners et al.Methods in enzymology, 272, 139-145 (1996-01-01) Cytochrome P450 2C9 phenotyping using low-dose tolbutamide.Alexander Jetter et al.European journal of clinical pharmacology, 60(3), 165-171 (2004-03-27) Biotransformation of tolbutamide to 4'-hydroxytolbutamide by the fungus Cunninghamella blakesleeana.Haihua Huang et al.Applied microbiology and biotechnology, 72(3), 486-491 (2006-02-24) Characterization of a novel CYP2C9 mutation (1009C>A) detected in a warfarin-sensitive patient.Shun-Bin Luo et al.Journal of pharmacological sciences, 125(2), 150-156 (2014-07-31) Metabolic characterization of meso-dihydroguaiaretic acid in liver microsomes and in mice.Jang Su Jeon et al.Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 76, 94-102 (2014-12-24) Inhibition of tolbutamide metabolism by substituted imidazole drugs in vivo: evidence for a structure-activity relationship.D J Back et al.British journal of pharmacology, 85(1), 121-126 (1985-05-01) Inhibition of tolbutamide metabolism by antimalarial drugs.J Karbwang et al.The Southeast Asian journal of tropical medicine and public health, 19(2), 235-241 (1988-06-01) Quantitative determination of tolbutamide and its metabolites in human plasma and urine by high-performance liquid chromatography and UV detection.L L Hansen et al.Therapeutic drug monitoring, 21(6), 664-671 (1999-12-22) Inhibitory effects of Hwang-Ryun-Hae-Dok-Tang on cytochrome P450 in human liver microsomes.Sang Yoon Lee et al.Xenobiotica; the fate of foreign compounds in biological systems, 45(2), 131-138 (2014-08-26) Gliclazide hydroxylation by rat liver microsomes.A Rieutord et al.Xenobiotica; the fate of foreign compounds in biological systems, 25(12), 1345-1354 (1995-12-01) The in-vitro effect of complementary and alternative medicines on cytochrome P450 2C9 activity.Kim D Mooiman et al.The Journal of pharmacy and pharmacology, 66(9), 1339-1346 (2014-04-16)

备注

RelatedAPI's